FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/066866 [Registered on: 06/05/2024] Trial Registered Prospectively
Last Modified On: 03/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparative Evaluation Of The Efficacy Of Standard Market Preparation Tablet And Swayamguptadi Vati In The Management Of Klaibya (Erectile Dysfunction) 
Scientific Title of Study   Comparative Evaluation of the efficacy of standard market preparation (Tablet) and swayamguptadivati in the management Of Klaibya (Erectile Dysfunction): A randomized clinical trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sourabh Deshmukh 
Designation  Professor 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Centre ,Salod Hirapur Wardha 
Address  Room No 30 Department of Kayachikitsa Mahatma gandhi ayurved college hospital and research centre Wardha MAHARASHTRA

Wardha
MAHARASHTRA
442001
India 
Phone  9404337799  
Fax    
Email  ayurrulz@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Trupti Deshmukh 
Designation  Assistant Professor 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Centre ,Salod Hirapur Wardha 
Address  Room No 32 Department of Balrog Mahatma gandhi ayurved college hospital and research centre Wardha MAHARASHTRA

Wardha
MAHARASHTRA
442001
India 
Phone  7020299894   
Fax    
Email  Truptithakre555@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sourabh Deshmukh 
Designation  Professor 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Centre ,Salod Hirapur Wardha 
Address  Room No 30 Department of Kayachikitsa Mahatma gandhi ayurved college hospital and research centre Wardha MAHARASHTRA

Wardha
MAHARASHTRA
442001
India 
Phone  9404337799  
Fax    
Email  ayurrulz@gmail.com  
 
Source of Monetary or Material Support  
The subjects will be recruited from Kayachikitsa OPD and IPD of Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha and peripheral camps 
 
Primary Sponsor  
Name  Mahatma Gandhi Ayurved College Hospital and Center 
Address  Room No 30 Department of Kayachikitsa Mahatma Gandhi ayurved college hospital and research centre Wardha MAHARASHTRA 442001 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sourabh Deshmukh  Mahatma Gandhi Ayurved College Hospital and Research Centre   OPD and IPD of Kayachikitsa Department Room no 30
Wardha
MAHARASHTRA 
9404337799

ayurrulz@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Mahatma Gandhi Ayurved College, Hospital & Research Centre, Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N528||Other male erectile dysfunction. Ayurveda Condition: KLAIBYAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugOther than Classical(1) Medicine Name: Standard Market Preparation Tablet, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 500(mg), Frequency: hs, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Water), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: SWAYAMGUPTADI VATI , Reference: Samhita, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: hs, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Water), Additional Information: -
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  65.00 Year(s)
Gender  Male 
Details  Patients willing to participate in the study and give written informed
consent.Patients with partial or complete erectile dysfunction
reported with symptoms.Each mentioned a patient with IIEF
identified sexual dysfunction.Patients having total testosterone level less than 249ng/mL 
 
ExclusionCriteria 
Details  Current treatment with antihypertensive medication.
Subject who have significant heart disease.
History of neurological disorder.
Homosexual person.
History of penile trauma, injury, surgery.
Subjects with history of significant central nervous system injuries
(including stroke or
spinal cord injury) within the last 6 month 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Improvement in the levels of Sr Testosterone  30 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in IIEF Questionnaire Scale  30 Days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   15/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The volunteers will be informed about the study protocol. willing participants will be randomly selected as per computer generated table. Clinical research format will be prepared and validated. Prior to the study approval will be taken from IEC, MGACH RC, Salod (H) Wardha and CTRI registration will be done. After selection, each participant will be tested individually and selected according to selection criteria. They will be divided into two groups as the trial is a parallel group, randomized, open clinical, standard controlled trial. It will include a 30 days treatment period and follow up on 0 and 30th day 
Close